Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer

Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer

Abstract Background Despite some therapeutic advances, improvement in survival rates of unresectable and/or metastatic pancreatic ductal adenocarcinoma (PDAC) has been minimal over recent decade. We aimed to evaluate the impact of different treatment sequences on clinical outcomes of advanced PDAC a...

Full description

Bibliographic Details
Main Authors: Mengjiao Fan, Guochao Deng, Yue Ma, Haiyan Si, Zhikuan Wang, Guanghai Dai
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Cancer
Subjects:
Pancreatic ductal adenocarcinoma
Treatment landscape
Treatment patterns
Treatment sequences
New chemotherapy regimens
Irinotecan
Online Access:https://doi.org/10.1186/s12885-024-11823-8

Internet

https://doi.org/10.1186/s12885-024-11823-8

Similar Items